CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
10.56
-0.08 (-0.75%)
At close: Dec 5, 2025, 4:00 PM EST
10.60
+0.04 (0.38%)
After-hours: Dec 5, 2025, 7:58 PM EST
Company Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure.
The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007.
CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
CorMedix Inc.
| Country | United States |
| Founded | 2006 |
| IPO Date | Mar 25, 2010 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 65 |
| CEO | Joseph Todisco |
Contact Details
Address: 300 Connell Drive, Suite 4200 Berkeley Heights, New Jersey 07922 United States | |
| Phone | 908 517 9500 |
| Website | cormedix.com |
Stock Details
| Ticker Symbol | CRMD |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001410098 |
| CUSIP Number | 21900C308 |
| ISIN Number | US21900C3088 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Joseph Todisco MBA | Chief Executive Officer and Director |
| Elizabeth Masson-Hurlburt B.A. | Executive Vice President, Chief Operating Officer and Chief Integration Officer |
| Dr. Matthew T. David M.D. | Executive Vice President and Chief Business Officer |
| Susan Blum | Executive Vice President and Chief Financial Officer |
| Kaufman Beth Zelnick Esq. | EVice President, Chief Legal and Compliance Officer and Corporate Secretary |
| Beth Steinbrenner | SVice President and Chief Human Resource Officer |
| Donna Ucci | Senior Vice President and Head of Global Quality |
| Dr. Tushar Mukherjee | Senior Vice President and Head of Technical Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 1, 2025 | SCHEDULE 13G | Filing |
| Nov 24, 2025 | 144 | Filing |
| Nov 14, 2025 | 144 | Filing |
| Nov 13, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Nov 12, 2025 | 10-Q | Quarterly Report |
| Nov 12, 2025 | 8-K | Current Report |
| Nov 10, 2025 | 144 | Filing |
| Nov 6, 2025 | 144 | Filing |
| Oct 24, 2025 | DEF 14A | Other definitive proxy statements |
| Oct 20, 2025 | 8-K | Current Report |